Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New analgesic agent described by Japanese academics

Jan. 10, 1997

Elan/Scherer Zydis formulation license agreement

Jan. 10, 1997

CCD-1042 progresses in trials

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

New analgesic drug candidate emerges from BioChem Pharma/Astra collaboration

Jan. 8, 1997

Dexketoprofen trometamol: An NSAID with improved safety and efficacy

Jan. 8, 1997

Hoechst Japan describes immunosuppressive peptides

Jan. 8, 1997

ImmuLogic files U.S. IND application for MS therapeutic

Jan. 7, 1997

First launch for Sumitomo antidepressant

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...